Clinical outcomes in patients with atrial fibrillation receiving amiodarone on NOACs vs. warfarin.
Ricardo AvendanoJorge RomeroFlorentino LupercioJuan Carlos DiazRenato QuispeAnjani GoliveAndrea NataleMario J GarciaAndrew K KrumermanLuigi Di BiasePublished in: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2018)
Among patients with AF taking amiodarone, there is no increased risk of stroke, major bleeding, or ICB with NOACs compared to warfarin.